ISRCTN81218776已完成不适用
A study of adjuvant chemotherapy for malignant glioma
Medical Research Council (MRC) (UK)0 个研究点目标入组 600 人开始时间: 2001年2月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 18-69
- •2. No previous treatment except surgery, corticosteroids, anticonvulsants or diuretics
- •3. Entry within 6 weeks of surgery
- •4. Other malignancies
- •5. Fitness for treatment
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Phase II study of adjuvant chemotherapy with gemcitabine and regional arterial infusion of nafamostat mesilate for the patients with resectable pancreatic cancerJPRN-UMIN000006163Jikei University school of Medicine30
已完成
2 期
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasisResectable colorectal cancer with hepatic metastasisJPRN-UMIN000014492Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine40
尚未招募
1 期
Phase l/ll study of adjuvant chemotherapy (TC therapy) after concurrent chemoradiation in cervical cancer with lymphadenopathyCervical cancer with lymphadenopathyJPRN-UMIN000004897The University of Tokushima Graduate School30
已完成
2 期
Feasibility study of adjuvant chemotherapy with alternate-day administrations of S-1 in patients with resected pancreatic cancerpancreatic cancerJPRN-UMIN000009936Fukushima Medical University Hospital, School of medicine30
招募中
1 期
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancerpancreatic cancerJPRN-UMIN000017715Osaka University Hospital10